Abstract
Several trials have reported an increased risk of fractures and falls after intermittent high-dose vitamin D. Treatment with loading doses of vitamin D may increase 1,25(OH)(2) vitamin D catabolism through changes in calcium/phosphate homeostasis and fibroblast growth factor-23 (FGF-23).
| Original language | English |
|---|---|
| Pages (from-to) | 550-556 |
| Number of pages | 7 |
| Journal | The Journal of Clinical Endocrinology and Metabolism |
| Volume | 98 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - Feb 2013 |
Keywords
- Aged
- Alendronate
- Bone Density
- Bone Density Conservation Agents
- Ergocalciferols
- Female
- Fibroblast Growth Factors
- Humans
- Male
- Middle Aged
- Osteoporosis
- Postmenopause
- Vitamin D
- Vitamin D Deficiency